Norbert Heimburger
38Patents
14h-index
33Co-inventors
81Inventor score
Filing activity: Jul 24, 1975 → Jun 6, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4297344A | Blood coagulation factors and process for their manufacture | Emerging Cross-Sectional Technologies | 129 | Expired |
| US4650678A | Readily dissolvable lyophilized fibrinogen formulation | Human Necessities | 115 | Expired |
| US4411794A | Process for the purification of the blood clotting factors, II, VII, IX and/or X | Human Necessities | 51 | Expired |
| US5407671A | One-component tissue adhesive and a process for the production thereof | Human Necessities | 38 | Expired |
| US4056484A | Stable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4960757A | Pasteurized human fibrinogen (HF), a process for its preparation, and its use | Human Necessities | 22 | Expired |
| US4670544A | Process for the manufacture of the cold insoluble globulin and pharmaceutical preparation containing it | Emerging Cross-Sectional Technologies | 22 | Expired |
| US4405603A | Method for rendering factors IX and X hepatitis-safe with calcium ions | Human Necessities | 20 | Expired |
| US4404187A | Method for rendering factors II and VII hepatitis-safe with a chelating agent | Human Necessities | 20 | Expired |
| US5043428A | Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6500427B1 | One-component tissue adhesive and a process for the production thereof | Human Necessities | 19 | Expired |
| US4915945A | Process for the preparation of the C1 inactivator | Human Necessities | 16 | Expired |
| US4562072A | Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby | Human Necessities | 16 | Expired |
| US5057414A | Method for the determination of the activity of serine proteases or serine protease inhibitors | Physics | 14 | Expired |
| US4442213A | Process for the preparation of plasminogen and plasminogen thus prepared | Chemistry; Metallurgy | 13 | Expired |
| US5424401A | Process for the preparation of a stable factor VIII | Chemistry; Metallurgy | 12 | Expired |
| US4579735A | Process for the pasteurization of human residual plasma | Human Necessities | 10 | Expired |
| US5136026A | Process for removing toxins from protein solutions | Chemistry; Metallurgy | 10 | Expired |
| US6239261A | Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof | Chemistry; Metallurgy | 9 | Expired |
| US4033824A | Process for the determination of plasminogen | Physics | 6 | Expired |
| US4106990A | Quantitative determination of antithrombin III | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5049545A | Insulin derivatives, a process for their preparation, and their use | Human Necessities | 6 | Expired |
| US4331766A | Collagen solution, process for its manufacture and its use | Physics | 6 | Expired |
| US4178368A | Method for the treatment of thromboembolism | Human Necessities | 6 | Expired |
| US4404134A | Collagen sponge | Physics | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.